EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Impact of propofol or sevoflurane on the renoprotective effect of remote ischaemic preconditioning in cardiac surgery: the HypnoRenalRIP randomised clinical trial

Alexander Zarbock, Ludwig Maximilian Schöne, John A Kellum, Joachim Gerss, Raphael Weiss, Hendrik Booke, Melanie Meersch

British Journal of Anaesthesia · 2025-12 · 135 (6) · 1626-1634

DOI: 10.1016/j.bja.2025.08.055 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2025-12. Verfasst von Alexander Zarbock und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Münster, Münster, Germany; Department of Anesthesiology…. Hauptthemen laut MEDLINE: Sevoflurane, Propofol, Ischemic Preconditioning, Cardiac Surgical Procedures. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, bioMérieux, Baxter International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Remote ischaemic preconditioning (RIPC) might reduce acute kidney injury after cardiac surgery. Protective effects appear to be restricted to patients with early and transient increases in two cell cycle arrest markers, tissue inhibitor of metalloproteinases-2 (TIMP-2) and insulin-like growth factor-binding protein 7 (IGFBP7), in urine. Studies suggest that propofol can attenuate the preconditioning effect on the myocardium. This study investigated whether propofol diminishes the renoprotective effect associated with the early transient increases in TIMP-2 and IGFBP7. METHODS: This was a single-centre, prospective randomised double-blind 2×2 factorial clinical trial of high-risk patients undergoing cardiac surgery. Patients were randomised to receive either propofol+sham-RIPC, propofol+RIPC, sevoflurane+sham-RIPC, or sevoflurane+RIPC. The primary outcome measure was the change in the product of urinary concentrations of TIMP-2 and IGFBP7 ([TIMP-2]·[IGFBP7]) from before to after the intervention. RESULTS: We enrolled 160 participants in the trial (propofol+sham-RIPC: n=20, propofol+RIPC: n=60, sevoflurane+sham-RIPC: n=20, sevoflurane+RIPC: n=60). The median change in [TIMP-2]·[IGFBP7] as an indicator of response to RIPC was greater in participants receiving sevoflurane (0.070; interquartile range, -0.120 to 0.418) compared with those receiving propofol (-0.015; interquartile range, -0.138 to 0.068; P=0.022). Conversely, elevated [TIMP-2]·[IGFBP7] as a sign of renal stress in response to surgery was detected in all groups except for sevoflurane+RIPC (P=0.001). There were no statistically significant differences in patient-centred outcomes between groups. CONCLUSIONS: Transient increases in [TIMP-2]·[IGFBP7] induced by RIPC, which were associated with renoprotective effects, were only seen with sevoflurane anaesthesia, but not when propofol was used. The association of biomarker concentrations and choice of anaesthetic agent suggests that propofol can attenuate the renoprotective effects of remote ischaemic preconditioning. CLINICAL TRIAL REGISTRATION: DRKS00014989.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SevofluranePropofolIschemic PreconditioningCardiac Surgical ProceduresAcute Kidney InjuryAnesthetics, InhalationAnesthetics, IntravenousHumansMaleFemaleTissue Inhibitor of Metalloproteinase-2AgedMiddle AgedDouble-Blind MethodInsulin-Like Growth Factor Binding ProteinsProspective StudiesBiomarkers

Stichwörter der Autor:innen

acute kidney injurybiomarkercardiac surgeryinsulin-like growth factor-binding protein 7propofolremote ischaemic preconditioningtissue inhibitor of metalloproteinases-2

Substanzen

SevofluranePropofolTissue Inhibitor of Metalloproteinase-2Insulin-Like Growth Factor Binding Proteinsinsulin-like growth factor binding protein-related protein 1Anesthetics, InhalationAnesthetics, IntravenousTIMP2 protein, humanBiomarkers

Autor:innen und Institutionen

  • Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Münster, Münster, Germany; Department of Anesthesiology, Critical Care and Pain Medicine, The University of Texas Health Scie…
  • Department of Anaesthesiology, Intensive Care Medicine and Pain Medicine, University Hospital Münster, Münster, Germany.
  • Center for Critical Care Nephrology, Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA.
  • Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.

Förderung

  • Deutsche Forschungsgemeinschaft
  • bioMérieux
  • Baxter International

Zitieren

APA

Zarbock, A., Schöne, L. M., Kellum, J. A., Gerss, J., Weiss, R., Booke, H., & Meersch, M. (2025). Impact of propofol or sevoflurane on the renoprotective effect of remote ischaemic preconditioning in cardiac surgery: the HypnoRenalRIP randomised clinical trial. British Journal of Anaesthesia, 135(6), 1626-1634. https://doi.org/10.1016/j.bja.2025.08.055

Vancouver

Zarbock A, Schöne LM, Kellum JA, Gerss J, Weiss R, Booke H, et al. Impact of propofol or sevoflurane on the renoprotective effect of remote ischaemic preconditioning in cardiac surgery: the HypnoRenalRIP randomised clinical trial. British Journal of Anaesthesia. 2025;135(6):1626-1634. doi:10.1016/j.bja.2025.08.055

BibTeX
@article{Zarbock2025,
  author = {Zarbock, Alexander and Schöne, Ludwig Maximilian and Kellum, John A and Gerss, Joachim and Weiss, Raphael and Booke, Hendrik and Meersch, Melanie},
  title = {Impact of propofol or sevoflurane on the renoprotective effect of remote ischaemic preconditioning in cardiac surgery: the HypnoRenalRIP randomised clinical trial},
  journal = {British Journal of Anaesthesia},
  year = {2025},
  volume = {135},
  number = {6},
  pages = {1626--1634},
  doi = {10.1016/j.bja.2025.08.055}
}
Kostenlos starten →